$288.22-$5.27 (-1.8%)
Columbia Seligman Technology and Information Fund Class I’s quoted price sits in the upper half of its reported 52-week range, 8.34% below the high.
Loading market information…
NASDAQ · THISX · USD
Stock price, dividends
Quote as of Oct 30, 2026, 12:07 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
T. Rowe Price Health Sciences Fund I Class’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
T. Rowe Price Health Sciences Fund I Class’s forward annual dividend is $10.26 per share, paid annual. The forward yield is 10.15% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
The fund's primary objective is to achieve long-term capital appreciation. To meet this goal, it typically invests at least 80% of its net assets (including any assets acquired through borrowing) in the common stocks of companies within the broad "health sciences" sector. This includes firms involved in the research, development, production, or distribution of products and services related to healthcare, medicine, or life sciences. While the fund maintains the flexibility to invest in companies of any size, the majority of its portfolio is expected to be allocated to large- and mid-capitalization companies.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:15 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$288.22-$5.27 (-1.8%)
Columbia Seligman Technology and Information Fund Class I’s quoted price sits in the upper half of its reported 52-week range, 8.34% below the high.
$93.47-$0.31 (-0.33%)
Victory 500 Index Fund Member Shares’s quoted price sits in the upper half of its reported 52-week range, 1.47% below the high.
$38.41+$0.64 (+1.69%)
T. Rowe Price Mid-Cap Value Adv’s quoted price sits in the upper half of its reported 52-week range, 2.86% below the high.
$38.73+$0.64 (+1.68%)
T. Rowe Price Mid-Cap Value Fund I Class’s quoted price sits in the upper half of its reported 52-week range, 2.79% below the high.
$29.37-$1.04 (-3.41%)
Sprott Physical Gold Trust’s quoted price sits in the lower half of its reported 52-week range, 30.18% below the high.
$22.64-$0.14 (-0.61%)
T. Rowe Price International Stock’s quoted price sits in the upper half of its reported 52-week range, 6.48% below the high.
$22.15-$0.14 (-0.63%)
T. Rowe Price International Stock Fund Class R’s quoted price sits in the upper half of its reported 52-week range, 6.58% below the high.
$53.39+$0.77 (+1.46%)
Allspring Special Mid Cap Value Fund - Class Inst’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
